Vertex Pharmaceuticals Other Countries Outsideofthe United Statesandthe United Kingdom — Total long-lived assets increased by 73.1% to $27.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 73.1%, from $15.60M to $27.00M.
An increase suggests significant capital investment or infrastructure expansion in these regions, whereas a decrease may indicate asset divestment, impairment, or a shift in geographic strategy.
This metric measures the total book value of non-current, tangible, and intangible assets located in geographic regions...
Comparable to 'Long-lived assets by geography' reported by multinational corporations to show the physical footprint of operations outside the home market.
vrtx_segment_other_total_long_lived_assets| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $15.40M | $14.60M | $15.90M | $15.60M | $27.00M |
| QoQ Change | — | -5.2% | +8.9% | -1.9% | +73.1% |
| YoY Change | — | -5.2% | +8.9% | -1.9% | +73.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.